日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Systematic identification of biomarker-driven drug combinations to overcome resistance

系统识别生物标志物驱动的药物组合以克服耐药性

Matthew G Rees, Lisa Brenan, Mariana do Carmo, Patrick Duggan, Besnik Bajrami, Michael Arciprete, Andrew Boghossian, Emma Vaimberg, Steven J Ferrara, Timothy A Lewis, Danny Rosenberg, Tenzin Sangpo, Jennifer A Roth, Virendar K Kaushik, Federica Piccioni, John G Doench, David E Root, Cory M Johanness

Project Inclusive Genetics: Exploring the impact of patient-centered counseling training on physical disability bias in the prenatal setting

包容性遗传学项目:探索以患者为中心的咨询培训对产前环境中身体残疾歧视的影响

Vaimberg, Emma; Demers, Lindsay; Ford, Eric; Sabatello, Maya; Stevens, Blair; Dasgupta, Shoumita

Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens

用于组合遗传筛选的同源 CRISPR-Cas9 酶

Fadi J Najm ,Christine Strand ,Katherine F Donovan ,Mudra Hegde ,Kendall R Sanson ,Emma W Vaimberg ,Meagan E Sullender ,Ella Hartenian ,Zohra Kalani ,Nicolo Fusi ,Jennifer Listgarten ,Scott T Younger ,Bradley E Bernstein ,David E Root ,John G Doench

Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities.

针对多种模式的 CRISPR-Cas9 基因筛选优化的文库

Sanson Kendall R, Hanna Ruth E, Hegde Mudra, Donovan Katherine F, Strand Christine, Sullender Meagan E, Vaimberg Emma W, Goodale Amy, Root David E, Piccioni Federica, Doench John G

Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool

利用 CRISPR/Cas9 介导的诱变技术创造新型蛋白质变体:将筛选副产物转化为发现工具

Katherine F Donovan, Mudra Hegde, Meagan Sullender, Emma W Vaimberg, Cory M Johannessen, David E Root, John G Doench

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

优化 sgRNA 设计以最大程度提高 CRISPR-Cas9 的活性并最大程度降低其脱靶效应

John G Doench #, Nicolo Fusi #, Meagan Sullender #, Mudra Hegde #, Emma W Vaimberg #, Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard, Herbert W Virgin, Jennifer Listgarten #, David E Root